The pacing therapies for congestive heart failure (PATH-CHF) study: rationale, design, and endpoints of a prospective randomized multicenter study11For a complete list of institutions and individuals participating in the PATH-CHF Study Group, see the Appendix.
- 1 March 1999
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 83 (5) , 130-135
- https://doi.org/10.1016/s0002-9149(98)01014-5
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Multisite Pacing for End‐Stage Heart Failure: Early ExperiencePacing and Clinical Electrophysiology, 1996
- Dual-chamber pacing in dilated cardiomyopathy: Insufficient sample size, heterogenous population and inappropriate end point may lead to erroneous conclusionsJournal of the American College of Cardiology, 1996
- Dual-chamber pacing with a short atrioventricular delay in congestive heart failure: A randomized studyJournal of the American College of Cardiology, 1995
- Results of atrioventricular synchronous pacing with optimized delay in patients with severe congestive heart failureThe American Journal of Cardiology, 1995
- Mechanism of hemodynamic improvement by dual-chamber pacing for severe left ventricular dysfunction: An acute Doppler and catheterization hemodynamic studyJournal of the American College of Cardiology, 1995
- Improvement of Cardiac Function in Patients with Severe Congestive Heart Failure and Coronary Artery Disease by Dual Chamber Pacing with Shortened AV DelayPacing and Clinical Electrophysiology, 1993
- Usefulness of physiologic dual-chamber pacing in drug-resistant idiopathic dilated cardiomyopathyThe American Journal of Cardiology, 1990
- Hemodynamic changes mimicking a vasodilator drug response in the absence of drug therapy after right heart catheterization in patients with chronic heart failure.Circulation, 1985